首页> 外国专利> HYPOXIA-INDUCIBLE FACTOR 1? HIF-1? VARIANTS AND METHODS FOR IDENTIFYING HIF-1? MODULATORS

HYPOXIA-INDUCIBLE FACTOR 1? HIF-1? VARIANTS AND METHODS FOR IDENTIFYING HIF-1? MODULATORS

机译:引起低氧的因素1? HIF-1?识别HIF-1的变体和方法?调制器

摘要

The present invention relates to a method for identifying compounds capable of modulating the function of a functional domain of human HIF-1 alpha , said method comprising (i) contacting a candidate compound with a variant of human HIF-1 alpha , said variant essentially lacking at least one functional domain of human HIF-1 alpha , or having a mutation making at least one functional domain of human HIF-1 alpha essentially inactive, said functional domain or domains being selected from the group consisting of (a) the PAS-B domain located in human HIF-1 alpha between amino acids 178 and 390, (b) the C-terminal nuclear localization sequence (NLS) located in human HIF-1 alpha essentially at amino acids 718 to 721, and (c) the transactivator / coactivator domain (N-TAD) located in human HIF-1 alpha essentially between amino acids 531 to 584, and (d) the transactivator / coactivator domain (C-TAD) located in human HIF-1 alpha essentially between amino acids 813 and 826, and (ii) determining the effect of the candidate compound on the said variant.
机译:本发明涉及一种鉴定能够调节人HIF-1α功能域功能的化合物的方法,所述方法包括(i)使候选化合物与人HIF-1α的变体接触,所述变体基本上缺乏人HIF-1α的至少一个功能域,或具有使人HIF-1α的至少一个功能域基本失活的突变,所述一个或多个功能域选自(a)PAS-B (b)位于人HIF-1 alpha中的C端核定位序列(NLS)基本上位于氨基酸718至721之间,以及(c)反式激活子/位于人HIF-1 alpha中的共激活域(N-TAD),基本上位于氨基酸531至584之间;(d)位于人HIF-1 alpha中的反激活体/共激活域(C-TAD),基本上位于氨基酸813和826之间和(ii)确定候选化合物对所述变体的作用。

著录项

  • 公开/公告号KR100648761B1

    专利类型

  • 公开/公告日2006-11-23

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20017005928

  • 申请日2001-05-10

  • 分类号G01N33/68;

  • 国家 KR

  • 入库时间 2022-08-21 20:41:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号